Finance

Lists
301206:SHE
Shandong Sanyuan Biotechnology Co Ltd
CNÂ¥23.86
-0.17%
(-0.040) 1D
Aug 31, 3:04:55 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301206...
Open
CNÂ¥23.92
High
CNÂ¥24.06
Low
CNÂ¥23.51
Mkt. cap
4.84B
Avg. vol.
1.41M
Volume
1.91M
Dividend
4.19%
Quarterly dividend
CNÂ¥0.25
Ex-dividend date
Jul 16, 2026
P/E ratio
56.94
52-wk high
CNÂ¥31.33
52-wk low
CNÂ¥21.81
EPS
CNÂ¥0.42
Shares outstanding
202.33M
No. of employees
441
Open
CNÂ¥23.92
High
CNÂ¥24.06
Low
CNÂ¥23.51
Mkt. cap
4.84B
Avg. vol.
1.41M
Volume
1.91M
Dividend
4.19%
Quarterly dividend
CNÂ¥0.25
Ex-dividend date
Jul 16, 2026
P/E ratio
56.94
52-wk high
CNÂ¥31.33
52-wk low
CNÂ¥21.81
EPS
CNÂ¥0.42
Shares outstanding
202.33M
No. of employees
441
About Shandong Sanyuan Biotechnology Co Ltd
CEO-
Employees441
FoundedJan 26, 2007
Headquarters-
SectorFood
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
158.11M
173.43M
224.78M
203.93M
Cost of goods sold
141.47M
147.64M
187.32M
165.96M
Cost of revenue
141.47M
147.64M
187.32M
165.96M
Research and development expenses
10.01M
9.62M
8.24M
10.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.54M
6.84M
10.17M
8.69M
Operating expense
21.09M
17.42M
18.59M
20.05M
Total operating expenses
162.55M
165.06M
205.92M
186.02M
Operating income
-4.44M
8.38M
18.86M
17.91M
Other non operating income
-51.93K
-68.24K
-3.14M
1.14M
EBT including unusual items
11.15M
27.66M
29.45M
28.05M
EBT excluding unusual items
11.08M
26.30M
27.62M
30.29M
Income tax expense
1.24M
3.65M
3.36M
3.75M
Effective tax rate
11.09%
13.18%
11.40%
13.35%
Other operating expenses
773.97K
1.06M
386.74K
712.38K
Net income
9.92M
24.01M
26.09M
24.31M
Net profit margin
6.27%
13.84%
11.61%
11.92%
Earnings per share
-
-
-
-
Interest and investment income
16.79M
19.38M
11.90M
11.24M
Interest expense
-
-
-
-
Net interest expenses
16.79M
19.38M
11.90M
11.24M
Depreciation and amortization charges
-
-
-
-
EBITDA
12.11M
26.75M
37.24M
39.12M
Gain or loss from assets sale
-36.37K
-65.75K
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps